MUVON is honored to be recognized for the second year in a row by the Top100 Swiss Startup community as one of the top 3 biotech startups in Switzerland. This recognition reflects the relentless efforts of our team in advancing regenerative medicine and our dedication to improving patients' lives for the better.
Since 2011, Switzerland celebrates the most promising Swiss startups at the TOP 100 Award Night. The Swiss Startup Ranking, organized by Venturelab, features startups that are not older than five years and are selected by a jury of early-stage investors.
Comments